Currently, optimally precise delivery of intracranial radiotherapy is possible with stereotactic radiosurgery and fractionated stereotactic radiotherapy. We present in this article a review of the underlying basic physical and radiobiological principles of fractionated stereotactic radiotherapy and review the clinical experience for ateriovenus malformations, pituitary adenomas, mengiomas, vestibular schwanomas, low grade astrocytomas, malignant gliomas, and brain metatases.
References
1.
SchwadeJ. G., HoudekP. V., LandyH. J.Small field stereotactic external beam radiation therapy of intracranial lesions: Fractionated treatment with a fixed-halo immobilization device. Radiol.176, 563–565 (1990).
2.
GillS. S., ThomasD. G. T., WarringtonA. P., BradaM.Relocateable frame for stereotactic external beam radiotherapy. Int. J. Radiat. Oncol. Biol. Phys.20, 608–612 (1991).
3.
DelannesM., DalyN. J., BonnetJ., SabatierJ., TremouletM.Fractionated radiotherapy of small inoperable lesions of the brain using a noninvasive stereotactic frame. Int. J. Radiat. Oncol. Biol. Phys.21, 749–755 (1991).
4.
HallE. J., BrennerD. J.The radiobiology of radiosurgery: Rationale for different treatment regimes for AVMs and malignancies. Int. J. Radiat. Oncol. Biol. Phys.25, 381–385 (1993).
5.
LoefflerJ. S., DunbarS. F., TarbellN.Early experience with stereotactic radiation therapy in the management of intracranial lesions: The first 1200 treatments. Int. J. Radiat. Oncol. Biol. Phys.27, 154 (1993).
6.
BrennerD. J., HallE. J.Stereotactic radiotherapy of intracranial tumors-an ideal candidate for accelerated treatment. Int. J. Radiat. Oncol. Biol. Phys.28, 1039–1041 (1994).
7.
MarksL. B.Conventional fractionated radiation therapy vs. radiosurgery for selected benign intracranial lesions (arteriovenous malformations, pituitary adenomas, and vestibular schwannomas). J. Neurooncol.17, 223–230 (1993).
8.
KalapurakalJ. A., IlahiZ., KepaA. G., BistaT., GoldmanS., TomitaT., MarymontM. H.Repositioning accuracy with the Laitinen frame for fractionated stereotactic radiation therapy in adult and pediatric brain tumors: Preliminary report. Radiology21, 157–161 (2001).
9.
MiranpuriA. S., ToméW. A., PaliwalB. R., KessleringC., MehtaM. P.Assesment of patient-independent intrinsic error for a noninvasive frame for fractionated stereotactic radiotherapy. Int J. Cancer, 96, 320–325 (2001).
10.
BurtonK. E., ThomasS. J., WhithneyD., RoutsisD. S., BensonR. J., BurnetN. G.Accuracy of a relocatable stereotatctic radiotherapy head frame evaluated by use of a depth helmet. Clin. Oncol. (R Coll. Radiol.)14, 31–39 (2002).
11.
SalterB. J., FussM., VollmerD. G., SadeghiA., BogaevC. A., CheekD. A., HermanT. S., HeveziJ. M.The TALON removable headframe system for stereotactic radiosurgey / radiotherapy: Measurement of repositioning accuracy. Int. J. Radiat. Oncol. Bio. Phys.51, 555–562 (2001).
12.
AlheitH., DornfeldS., DawelM., AlheitM., HenzelB., StecklerK., BlankH., GyerP.Patient position reproducibility in fractionated stereotactically guided conformal radiotherapy using the BrainLab mask system. Strahlenther Onkol.177, 264–268 (2001).
13.
BovaF. J., BuattiJ. M., FriedmanW. A., MendenhallW. M., YangC. C., LiuC. L.The University of Florida frameless high-precision stereotactic radiotherapy system. Int. J. Radiat. Oncol. Biol. Phys.38, 875–882 (1997).
14.
MeeksS. L., BovaF. J., WagnerT. H., BuattiJ. M., FriedmanW. A., FooteK. D.Image localization for frameless stereotactic radiotherapy. Int. J. Radiat. Oncol. Biol. Phys.46, 1291–1299 (2000).
15.
AyyangerK. M., JiangS. B.Do we need Monte Carlo treatment planning for linac-based radiosurgery? A case study. Med. Dosim.23, 161–167, (1998).
16.
ToméW. A., MeeksS. L., BuattiJ. M., BovaF. J., FriedmanW. A., ZuofengL.A High-Precision System for Conformal Intracranial Radiotherapy. Int. J. Radiat. Oncol. Biol. Phys.47, 1137–1143 (2000).
17.
ToméW. A., MeeksS. L., McNuttT. R., BuattiJ. M., BovaF. J., FriedmanW. A., MehtaM. P.Optically guided intensity modulated radiotherapy. Radiother. Oncol.61, 33–44 (2001).
18.
YeungD., PaltaJ., FontanesiJ., KunL.Systematic Analysis of Errors in target Localization and Treatment Delivery in Stereotactic Radiosurgery (SRS). Int. J. Radiat. Oncol. Biol. Phys.28, 493–498 (1994).
19.
PereraT., MoseleyJ., MunroP.Subjectivity in Interpretation of Portal Films. Int. J. Radiat. Oncol. Biol. Phys.45, 529–534 (1999).
20.
OndraS. L., TrouppH., GeorgeE. D.The natural history of symptomatic arteriovenous malformations of the brain: A 24-year follow-up assessment. J. Neurosurgery73, 387–391 (1990).
21.
SpetzlerR. F., MartinN. A.A proposed grading system for arteriovenous malformations. J. Neurosurgery65, 476–483 (1986).
22.
JohnsonR. T.Radiotherapy of cerebral angiomas. With a note on some problems in diagnosis, Cerebral Angiomas in Advances in Diagnosis and Therapy. Eds. PiaH. W., GleaveJ. R. W., GroteE., Springer-Verlag, New York (1975).
23.
KjellbergR. N., HanamuraT., DavisK. R.Bragg-peak proton-beam therapy for arteriovenous malformations of the brain, NEJM.309, 269–274 (1983).
24.
FriedmanW. A., BovaF. J., MendenhallW. M., Linear accelerator radiosurgery for arteriovenous malformations: The relationship of size to outcome. J. Neurosurg.82, 180–189 (1995).
25.
EllisT. L., FriedmanW. A., BovaF. J.An Analysis of Treatment Failures After Radiosurgery for Arteriovenous Malformations. J. Neurosurgery89, 104–110 (1998).
26.
AoyamaH., ShiratoH., NishiokaT., KageiK., OnimaruR., SuzukiK., UshikoshiS., HoukinK., KurodaS., AbeH., MiyasakaK.Treatment outcome of single or hypofractionated single-isocentric stereotactic irradiation (STI) using a linear accelerator for intracranial arteriovenous malformation. Radiother. Oncol59, 323–328 (2001).
27.
McCordM. W., BuattiJ. M., FennellE. M.Radiotherapy for Pituitary Adenoma: Long-Term Outcome and Sequelae. Int. J. Radiat. Oncol. Biol. Phys.39, 437–444 (1997).
28.
MitsomuriM., ShreiveD. C., AlexanderE.Initial clinical results of Linac-based stereotactic radiosurgery and stereotactic radiotherapy for pituitary adenomas. Int. J. Radiat. Oncol. Biol. Phys.42, 573–580 (1998).
29.
JalaliR., BradaM., PerksJ. R., WarringtonA. P., TraishD., BurchellL., McNairH., ThomasD. G., RobinsonS., JohnstonD. G.Stereotactic conformal radiotherapy for pituitary adenomas: Technique and preliminary experience, Clin. Endocrinol.52, 695–702 (2000).
30.
LawrenceJ. H., LinfootJ. A.Treatment of acromegaly, Cushing's disease and Nelson's Syndrome. West J. Med.133, 197–202 (1980).
31.
KjellbergR. N., ShintaniA., FranztA. G.Proton beam therapy for acromegaly. N. Engl. J. Med.278, 689–695 (1968).
32.
MinakovaYe. L., KirpatovskayaL.Ye., Lyass, F. M. Proton beam therapy with pituitary tumors. Med. Radiol. (Mosk)28, 7–13 (1983).
CondraK. S., BuattiJ. M., MendenhallW. M., FriedmanW. A., MarcusR. B., RhotonA. L.Benign Meningiomas: Primary Treatment Selection Affects Survival. Int. J. Radiat. Oncol. Biol. Phys.39, 427–436 (1997).
35.
LunsfordL. D.Contemporary management of meningiomas: Radiation therapy as an adjuvant and radiosurgery as an alternative to surgical removal?J. Neurosurgery80, 187–190 (1994).
36.
BuattiJ. M., BovaF. J., FriedmanW. A., MeeksS. L., MarcusR. B.Jr., MickleJ. P., EllisT. L., MendenhallW. M.Preliminary Experience with Frameless Stereotactic Radiotherapy. Int. J. Radiat. Oncol. Biol. Phys.42, 591–599 (1998).
37.
DebusJ., WuendrichM., PirzkallA., HoessA., SchlegelW., ZunaI., Engenhart-CabillicR., WannenmacherM.High efficacy of fractionated stereotactic radiotherapy of large base-of-skull meningiomas: Long term results, J. Clin. Oncol.19, 3547–3553 (2001).
38.
FlickingerJ. C., LunsfordL. D., LinskeyM. E.Gamma knife radiosurgery for acoustic tumors: Multivariate analysis of four year results. Radiother. Oncol.27, 91–98 (1993).
39.
LunsfordL. D., KondziolkaD., FlickingerJ. C.Acoustic neuroma management: Evolution and revolution. Radiosurgery 1997, pp 1–7. Ed., KondziolkaD., Karger, Basel, Switzerland (1998).
40.
FooteK. D., FriedmanW. A., BuattiJ. M., MeeksS. L., BovaF. J., KubilisP. S.An analysis of risk factors in radiosurgery for vestibular schwannoma. Neurosurgery95, 440–449 (2001).
41.
VarlottoJ. M., ShrieveD. C., AlexanderE.Fractionated stereotactic radiotherapy for the treatment of acoustic neuromas: Preliminary results. Int. J. Radiat. Oncol. Biol. Phys.36, 141–145 (1998).
AndrewsD. W., SuarezO., GoldmanH. W., DownesM. B., BednarzG., CornB. W., Werner-WasikM, RosenstaockJ., CuranW. J.Stereotactic radiosurgery and fractionated radiotherapy for the treatment of acoustic schwannomas: Comparative observations of 125 patients treated at one institution. Int. J. Radiat. Oncol. Biol. Phys.50, 1265–1278 (2001).
44.
PoenJ. C., GolbyA. J., ForsterK. M., MartinD. P., ChinnD. M., HancockS. L., AdlerJ. R.Jr. Fractionated stereotactic radiosurgery and preservation of hearing in patients with vestibular schwannoma: A preliminary report. Neurosurgery45, 1299–1305 (1999).
45.
ShiratoH., SakamotoT., TakeichiN., AoyamaH., SuzukiK., KageiK., NishiokaT., FukudaS., SawamuraY., MiyasakaK.Fractionated stereotactic radiotherapy for vestibular schwannoma (VS): Comparison between cystic-type and solid-type VS. Int. J. Radiat. Oncol. Biol. Phys.48, 1395–1401 (2000).
46.
MeijerO. W., WolbersJ. G., BaayenJ. C., SlotmanB. J.Fractionated stereotactic radiation therapy and single high-dose radiosurgery for acoustic neuroma: Early results of a prospective clinical study. Int. J. Radiat. Oncol. Biol. Phys.46, 45–49 (2000).
ZabelA., DebusJ., ThilmannC., SchlegelW., WannenmacherM.Management of benign cranial nonacoustic schwannomas by fractionated stereotactic radiotherapy. Int J. Cancer96, 356–362 (2001).
49.
SheperdS. F., LaingR. W., CosgroveV. P., WarringtonA. P., HinesF., AshleyS. E., BradaM.Hypofractionated stereotactic radiotherapy in the management of recurrent gliomas. Int. J. Rad. Oncol. Biol. Phys.37, 393–398 (1997).
50.
ShrieveD. C., KooyH. M., TarbellN. J., LoefflerJ. S.Fractionated Stereotactic Radiotherapy. Important Advances in Oncology, pp 205–224. Eds., DeVitaV. T., HellmansS. and RosenbergS. A., Lippincott-Raven Publishers, Philadelphia (1996).
51.
HudesR. S., CornB. W., Werner-WasikM., AndrrewsD., RosenstockJ., ThoronL., DowenesB., CurranW. J.A Phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma. Int J Radiat Oncol Biol Phys43, 293–298 (1999).
52.
ChoK. H., HallW. A., GerbiB. J., HigginsP. D., McGuireW. A., ClarkH. B.Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade glioma. Int J Radiat Oncol Biol Phys45, 1133–1141 (1999).
53.
GlassJ., SilvermanC. L., AxelrodR., CornB., AndrewsD.Fractionated stereotactic radiotherapy with cis-platinum radiosensitization in the treatment of recurrent, progressive, or persistent malignant astrocytoma. Am. J. Clin. Oncol.20, 226–229 (1997).
54.
LedermanG., WronskiM., ArbitE., OdaimiM., WertheimS., LombardiE., WrzolekM.Treatment of recurrent Glioblastoma multiforme using fractionated stereotactic radiosurgery and concurrent paclitaxel. Am. J. Clin. Oncol.23, 155–159 (2000).
55.
PatchellR. A., TibbsP. A., WalshJ. W.A randomized trial of surgery in the treatment of single metastases to the brain. N. Engl. J. Med.322, 494–500 (1990).
56.
SanghaviS, MiranpuriB. S., ChappellR., MabantaS., SuhJ., RegineW., WeltmanE., SneedP., GoetschS., BrenemanJ., SperdutoP., BuattiJ., ScottC., MehtaM.Multi-institutional survival analysis of brain metastases patients treated with radiosurgery, stratified by RTOG RPA classification. Int. J. Radiat. Oncol. Biol Phys.45, 171 (1999).
57.
LaingR. W., WarringtonA. P., HinesF., GrahamJ. D., BradaM.Fractionated stereotactic external beam radiotherapy in the management of brain metastases. Eur. J. Ca.29, 1387–1391 (1993).
58.
TokuuyeK., AkineY., SumiM.Fractionated stereotactic radiotherapy of small intracranial malignancies. Int. J. Radiat. Oncol. Biol. Phys.42, 989–994 (1998).
59.
IkushimaH., TokuuyeK., SumiM., KagamiY., MurayamaS., IkedaH., TanakaM., OyamaH., ShibuiS., NormuraK.Fractionated stereotactic radiotherapy of brain metastases from renal cell carcinoma. Int. J. Radiat. Oncol. Biol. Phys.48, 1389–1393 (2000).
60.
LedermanG., WronskiM., FineM.Fractionated radiosurgery for brain metastatses in 43 patients with breast carcinoma. Breast Cancer Res. Treat.65, 145–154 (2001).
CastroJ. R., CharD. H., PettiP. L.15 years experience with helium ion radiotherapy for uveal melanoma. Int. J. Radiat. Oncol. Biol. Phys.39, 989–996 (1997).
63.
MunzenriderJ. E.Proton therapy for uveal melanomas and other eye lesions. Strahlenther. Onkol.175, 68–73 (1999).
64.
DebusJ., Schulz-ErtnerD., SchadL., EssigM., RheinB., ThillmannC. O., WannenmacherM.Stereotactic fractionated radiotherapy for chordromas and chondrosarcomas of the skull base. Int. J. Radiat. Oncol. Biol. Phys.47, 591–596 (2000).
65.
XiaoJ, XuG., MiaoY.Fractionated stereotactic radiosurgery for 50 patients with recurrent or residual nasopharyngeal carcinoma. Int. J. Radiat. Oncol. Biol. Phys.51, 164–170, (2001).
66.
BovaF. J., FriedmanW. A.Stereotactic angiography: An inadequate database for radiosurgery. Int. J. Radiat. Oncol. Biol. Phys.20, 891–895 (1991).
67.
MackieT. R., BalogJ., RuchalaK., “Tomotherapy,”Seminars Radiat Oncol9, 108–117 (1999).
